TrialJournal of clinical psychopharmacology2014

A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder.

Angelo Sambunaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.